Condition

Neuroendocrine Prostate Cancer (NEPC) clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• First-in-human ML261 CAR T therapy for relapsed/refractory SCLC and select neuroendocrine cancers

  This early-phase study tests whether a patient’s own ML261 CAR T cells can be safely given to see if they help people with relapsed or refractory SCLC or certain neuroendocrine cancers.

  Recruiting at 7 sites Phase 1 Moonlight Bio, Inc · St Louis, Missouri and 6 other locations · NCT07488923

• Testing Peluntamig for Neuroendocrine Carcinomas

  This study is testing a new drug called Peluntamig to see if it can safely help people with different types of neuroendocrine cancers, either on its own or with chemotherapy.

  Recruiting at 15 sites Phase 1/2 Phanes Therapeutics · Duarte, California and 14 other locations · NCT05652686

Related topics

Quick answers

How many Neuroendocrine Prostate Cancer (NEPC) clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →